InterVenn: InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry
SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced... Read MoreThe post InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry appeared first on citybiz.
Read full article »
InterVenn is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry.
Read more